• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化中的关节炎——单中心队列与已发表病例报告/系列的比较及文献综述

Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.

作者信息

Peretz Anne Sofie Rosenborg, Bryrup Thomas, Faurholt-Jepsen Daniel, Nielsen Christoffer Tandrup Holst

机构信息

Center for Rheumatology and Spine Diseases, University Hospital - Rigshospitalet, Frederiksberg, Denmark.

Copenhagen Research Center for Autoimmune Connective Tissue Diseases (COPEACT), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

出版信息

APMIS. 2025 Aug;133(8):e70058. doi: 10.1111/apm.70058.

DOI:10.1111/apm.70058
PMID:40761185
Abstract

Cystic fibrosis (CF) is commonly associated with musculoskeletal issues including inflammatory arthritis, CF arthritis. We present a retrospective cohort study which aims to describe the clinical characteristics, prevalence, and demographic associations of CF arthritis using both a clinical and literature cohort. We identified adult CF patients (≥ 18 years) with arthritis from the rheumatology clinic at Rigshospitalet (2020-2022). The clinical cohort (CC) was reviewed through electronic medical records. Literature cases were identified by searching online databases for relevant studies, case reports, and reviews on CF arthritis. Eleven CF patients with arthritis were identified (CC) from our clinic and 54 cases from the literature (literature cohort, LC). Both cohorts showed equal gender distribution. In the LC, arthritis onset had a median age of 11 years (range 2-28), while in the CC it was 26 years (range 13-43). Clinical features were similar in both cohorts: the majority had episodic relapsing arthritis, with two-thirds having mono-/oligoarthritis and one-third polyarthritis. Large joints were most commonly affected. No clear link to pulmonary disease or serologic markers was found. Immunosuppressive treatment was safe. CF arthritis is a heterogeneous condition, presenting as non-erosive, episodic oligo- or polyarthritis affecting both large and small joints.

摘要

囊性纤维化(CF)通常与肌肉骨骼问题相关,包括炎性关节炎、CF 关节炎。我们开展了一项回顾性队列研究,旨在通过临床队列和文献队列描述 CF 关节炎的临床特征、患病率及人口统计学关联。我们从 Rigshospitalet 的风湿病诊所(2020 - 2022 年)中确定了患有关节炎的成年 CF 患者(≥18 岁)。通过电子病历对临床队列(CC)进行回顾。通过在线数据库搜索有关 CF 关节炎的相关研究、病例报告和综述来确定文献病例。我们诊所确定了 11 例患有关节炎的 CF 患者(临床队列),从文献中确定了 54 例病例(文献队列,LC)。两个队列的性别分布相同。在文献队列中,关节炎发病的中位年龄为 11 岁(范围 2 - 28 岁),而在临床队列中为 26 岁(范围 13 - 43 岁)。两个队列的临床特征相似:大多数患者为发作性复发性关节炎,三分之二为单/寡关节炎,三分之一为多关节炎。大关节最常受累。未发现与肺部疾病或血清学标志物有明确关联。免疫抑制治疗是安全的。CF 关节炎是一种异质性疾病,表现为非侵蚀性、发作性寡关节炎或多关节炎,累及大关节和小关节。

相似文献

1
Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.囊性纤维化中的关节炎——单中心队列与已发表病例报告/系列的比较及文献综述
APMIS. 2025 Aug;133(8):e70058. doi: 10.1111/apm.70058.
2
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
3
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
4
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
5
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.依伐卡托(Ataluren)及类似化合物(针对 I 类提前终止密码子突变的特异性治疗药物)治疗囊性纤维化。
Cochrane Database Syst Rev. 2023 Mar 3;3(3):CD012040. doi: 10.1002/14651858.CD012040.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Rheumatoid arthritis in a patient with cystic fibrosis: challenging treatment options.囊性纤维化患者的类风湿关节炎:具有挑战性的治疗选择。
BMJ Case Rep. 2020 Sep 6;13(9):e234305. doi: 10.1136/bcr-2020-234305.
2
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.囊性纤维化与铜绿假单胞菌:宿主-微生物界面。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00138-18. Print 2019 Jun 19.
3
Clinical manifestations and risk factors of arthropathy in cystic fibrosis.囊性纤维化相关关节炎的临床表现及危险因素。
Respir Med. 2019 Feb;147:66-71. doi: 10.1016/j.rmed.2019.01.003. Epub 2019 Jan 17.
4
Arthritis in sarcoidosis: A multicentric study from India.结节病中的关节炎:一项来自印度的多中心研究。
Int J Rheum Dis. 2018 Sep;21(9):1728-1733. doi: 10.1111/1756-185X.13349. Epub 2018 Sep 5.
5
Rheumatoid arthritis.类风湿关节炎
Lancet. 2016 Oct 22;388(10055):2023-2038. doi: 10.1016/S0140-6736(16)30173-8. Epub 2016 May 3.
6
Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy.超声和磁共振成像评估有症状的囊性纤维化关节病患者的关节疾病。
J Cyst Fibros. 2016 Jul;15(4):e35-40. doi: 10.1016/j.jcf.2015.12.022. Epub 2016 Jan 20.
7
Safe and effective tumour necrosis factor-α inhibitor (etanercept) treatment of chronic episodic arthritis in a patient with cystic fibrosis.肿瘤坏死因子-α抑制剂(依那西普)对一名囊性纤维化患者慢性发作性关节炎的安全有效治疗
Scand J Rheumatol. 2016 Jul;45(4):330-1. doi: 10.3109/03009742.2015.1122834. Epub 2016 Jan 20.
8
Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis.支气管扩张症是类风湿关节炎慢性细菌感染诱导自身免疫的模型。
Arthritis Rheumatol. 2015 Sep;67(9):2335-42. doi: 10.1002/art.39226.
9
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.囊性纤维化肺病中的炎症:发病机制与治疗。
J Cyst Fibros. 2015 Jul;14(4):419-30. doi: 10.1016/j.jcf.2015.03.003. Epub 2015 Mar 23.
10
Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis.类风湿关节炎中的肺部、关节和针对瓜氨酸化蛋白的免疫。
Nat Rev Rheumatol. 2014 Nov;10(11):645-53. doi: 10.1038/nrrheum.2014.115. Epub 2014 Jul 29.